ask="8.50"
ask_size="200"
average_daily_volume="236673"
bid="7.10"
bid_size="1000"
book_value="3.42"
change="+0.21"
change_from_200_day_moving_average="0.03"
change_from_50_day_moving_average="0.67"
change_from_52_week_high="-4.20"
change_From_52_week_low="2.71"
change_in_percent="+2.60%"
close="8.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.92"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="5020000"
high="8.36"
high_52_weeks="12.50"
last_trade_date="1/9/2017"
last_trade_price="8.30"
last_trade_size="6934"
last_trade_time="4:00pm"
low="7.96"
low_52_weeks="5.59"
market_capitalization="100.95M"
moving_average_200_day="8.27"
moving_average_50_day="7.63"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.50"
open="8.14"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.38%"
percent_change_from_50_day_moving_average="+8.84%"
percent_change_from_52_week_high="-33.60%"
percent_change_from_52_week_low="+48.48%"
previous_close="8.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.36"
price_per_sales="1.43"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="1.30"
stock_exchange="NCM"
symbol="REPH"
volume="107871"
weeks_range_52="5.59 - 12.50"
